Cal. NAACP Resolution: End Use of Psyc Drugs on FosterYouth
AHRP applauds the California chapter of the NAACP for unanimously passing a resolution to end the abusive prescribing of psychotropic drugs for children in foster care!
-
-
Potent Narcotic ‘Lollipop’ Becomes Best Seller_WSJ
Off-label prescribing of drugs for unapproved uses puts consumers at high risk of harm–but it is the single most lucrative marketing strategy.
-
Separating the Facts from the Propaganda_Latest Findings of Depression Study
Today's news report circulated by the media about the negative findings of a much touted, but uncontrolled observational study of depression (STAR*D) promotes the business interests of SSRI antidepressant drug manufacturers.
-
Infant Mental Health Screen-a Gov-approved Assault
An Orwellian nightmare is being implemented on infants even as the evidence demonstrates that the psychiatry's practice guidelines are corrupted by
industry. -
Scientific Fraud: Eric Poehlman / Richard Borison
Medical researchers who commit fraud and research misconduct are caught only when a person of conscience steps up to the plate and blows the whistle. There are no systemic, independent checks and balances to prevent research fraud or abuse of patients.
-
14 deaths force halt to drug in Canada – Hyperactivity remedy called threat to kids
http://www.nj.com/news/ledger/index.ssf?/base/news-20/1108104141208160.xml Star-Ledger 14 deaths force halt to drug in Canada Hyperactivity remedy called threat to kids Friday, February 11, 2005 BY CAROL ANN CAMPBELL Safety concerns have clouded the future of another blockbuster medication, this one a hyperactivity drug prescribed to 700,000 Americans, most of them children. Health officials in…
-
Public Comments Re: Smallpox Vaccine Trial on 2 to 5 Year Old Children, Pg 2
Public Comments Re: Smallpox Vaccine Trial on 2 to 5 Year Old Children Being proactive is generally a good idea. But in the absence of a definitive outbreak it is difficult to justify exposing pediatric patients to potential risks such as neurologic complications which may not show up for years….
-
Evidence of Drug Harm that the FDA Sought to Suppress
Evidence of Antidepressant Harm that the FDA Sought to Suppress from FDA’s Public Advisory Committee Meeting on February 2 Evidence was presented on February 2 at AHRP’s press briefing by the following scientists: David Healy, MD, Director of the North Wales Department of Psychological Medicine and Visiting Professor, University of…
-
Bitter Medicine: Pills, Profit & the Public Health – ABC News
Date: Thu, 30 May 2002 14:14:47 -0400 From: Vera Subject: Bitter Medicine: Pills, Profit & the Public Health_ABC News ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI On May 17 The Wall Street Journal reported (in a front page article) that drug…
-
FDA Slaps Pfizer on Zoloft Ads After AHRP Files Complaint
FDA Slaps Pfizer on Zoloft Ads After AHRP Files Complaint Sat, 07 May 2005 On November 4, 2004, AHRP filed a complaint with the FDA about a two page Pfizer advertisement for its SSRI antidepressant, Zoloft. The ad appeared in The New York Times Magazine in October 2004, but Pfizer…
-
Pfizer PainKiller Bextra withdrawn from market, New Boxed Warnings for Celebrex
Pfizer PainKiller Bextra withdrawn from market, New Boxed Warnings for Celebrex Thu, 07 Apr 2005 Pfizer’s withdrawal of the COX-2 pain reliever, Bextra, from the market because of potentially lethal side effects, including increased risk of cardiovascular malfunction and severe rash, validates Dr. David Graham’s analysis. This FDA medical expert…
-
FDA Regulators Accused of Trying to Quash Testimony About Cardiac Risks of Painkillers – NYT
FDA Regulators Accused of Trying to Quash Testimony About Cardiac Risks of Painkillers – NYT Sat, 12 Feb 2005 A New York Times front page report announces that President Bush will veto any limits on the Medicare prescription drug giveaway. The administration is adamant about transfering $724 billion in taxpayer…